Accuracy of Self-Report and Pill-Count Measures of Adherence in the FEM-PrEP Clinical Trial: Implications for Future HIV-Prevention Trials

Oral emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) has been evaluated as pre-exposure prophylaxis (PrEP). We describe the accuracy of self-reported adherence to FTC/TDF and pill counts when compared to drug concentrations in the FEM-PrEP trial. Using drug concentrations of plasma tenofovir (...

Descripción completa

Detalles Bibliográficos
Autores principales: Agot, Kawango, Taylor, Douglas, Corneli, Amy L., Wang, Meng, Ambia, Julie, Kashuba, Angela D. M., Parker, Caleb, Lemons, Ansley, Malahleha, Mookho, Lombaard, Johan, Van Damme, Lut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415940/
https://www.ncbi.nlm.nih.gov/pubmed/25100053
http://dx.doi.org/10.1007/s10461-014-0859-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415940/
https://www.ncbi.nlm.nih.gov/pubmed/25100053
http://dx.doi.org/10.1007/s10461-014-0859-z

Ejemplares similares